MGRM Stock Overview
Focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Monogram Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.97 |
| 52 Week High | US$4.90 |
| 52 Week Low | US$1.53 |
| Beta | 0 |
| 11 Month Change | -19.59% |
| 3 Month Change | -30.14% |
| 1 Year Change | -35.83% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -83.23% |
Recent News & Updates
Shareholder Returns
| MGRM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.0% | 1.5% | 2.2% |
| 1Y | -35.8% | 20.8% | 31.6% |
Return vs Industry: MGRM underperformed the US Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: MGRM underperformed the US Market which returned 31.6% over the past year.
Price Volatility
| MGRM volatility | |
|---|---|
| MGRM Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MGRM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MGRM's weekly volatility has decreased from 17% to 11% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 28 | Ben Sexson | www.monogramorthopedics.com |
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.
Monogram Technologies Inc. Fundamentals Summary
| MGRM fundamental statistics | |
|---|---|
| Market cap | US$67.60m |
| Earnings (TTM) | -US$15.73m |
| Revenue (TTM) | US$365.00k |
185.2x
P/S Ratio-4.3x
P/E RatioIs MGRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MGRM income statement (TTM) | |
|---|---|
| Revenue | US$365.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$365.00k |
| Other Expenses | US$16.10m |
| Earnings | -US$15.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.46 |
| Gross Margin | 100.00% |
| Net Profit Margin | -4,310.41% |
| Debt/Equity Ratio | 0% |
How did MGRM perform over the long term?
See historical performance and comparison